HO-1 was evaluated as a biomarker of pre-clinical leprosy and we observed a 59.26% specificity and a 73.9% sensitivity in distinguishing the HC-DD versus HC-NDD groups (Table 1, Fig. 3). This evidence concerns the gene HMOX1 and leprosy.